SEC Comment Letter for AVITA Medical, Inc. (RCEL, AVHHL) (CIK 0001762303) (RCEL) — Mar 19, 2021

AVITA Medical, Inc. (RCEL, AVHHL) (CIK 0001762303)
Date: March 19, 2021 · CIK: 0001762303 · Accession: 0000000000-21-003345

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 19, 2021

Author

Sean Ekins

Form

UPLOAD

Company

AVITA Medical, Inc. (RCEL, AVHHL) (CIK 0001762303)

Letter

United States securities and exchange commission logo March 19, 2021 Sean Ekins VP of Finance AVITA Medical, Inc. 28159 Avenue Stanford Suite 220 Valencia, CA 91355 Re:AVITA Medical, Inc. Form 10-K for the fiscal year ended June 30, 2020 Filed August 27, 2020 File No. 1-39059 Dear Mr. Ekins: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
March 19, 2021
Sean Ekins
VP of Finance
AVITA Medical, Inc.
28159 Avenue Stanford
Suite 220
Valencia, CA 91355
Re:AVITA Medical, Inc.
Form 10-K for the fiscal year ended June 30, 2020
Filed August 27, 2020
File No. 1-39059
Dear Mr. Ekins:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io